Brooks O'Neil
Stock Analyst at Lake Street
(0.66)
# 4,115
Out of 5,154 analysts
34
Total ratings
29.41%
Success rate
-20.87%
Average return
Main Sectors:
Stocks Rated by Brooks O'Neil
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MDXG MiMedx Group | Maintains: Buy | $12 → $10 | $4.50 | +122.22% | 2 | Jan 20, 2026 | |
| LFMD LifeMD | Maintains: Buy | $14 → $8 | $3.00 | +166.67% | 4 | Nov 18, 2025 | |
| TNDM Tandem Diabetes Care | Downgrades: Hold | $75 → $12 | $21.14 | -43.24% | 2 | Aug 11, 2025 | |
| RCEL AVITA Medical | Maintains: Buy | $14 → $8 | $4.75 | +68.42% | 7 | Aug 11, 2025 | |
| PIII P3 Health Partners | Maintains: Buy | $50 → $20 | $2.31 | +765.80% | 2 | Apr 21, 2025 | |
| LMAT LeMaitre Vascular | Maintains: Buy | $105 → $110 | $107.39 | +2.43% | 2 | Feb 28, 2025 | |
| BBNX Beta Bionics | Initiates: Buy | $30 | $10.61 | +182.75% | 1 | Feb 24, 2025 | |
| LFVN LifeVantage | Initiates: Buy | $26 | $4.88 | +432.79% | 1 | Dec 19, 2024 | |
| HROW Harrow | Maintains: Buy | $45 → $55 | $36.35 | +51.31% | 3 | Oct 4, 2024 | |
| ATEC Alphatec Holdings | Maintains: Buy | $32 → $18 | $12.23 | +47.18% | 4 | Sep 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $20 | $8.70 | +129.89% | 1 | Aug 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $2.79 | +79.21% | 1 | Jun 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $26 | $23.88 | +8.88% | 2 | Feb 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $11 | $0.20 | +5,427.64% | 1 | Apr 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $128 | $23.17 | +450.28% | 1 | Sep 15, 2020 |
MiMedx Group
Jan 20, 2026
Maintains: Buy
Price Target: $12 → $10
Current: $4.50
Upside: +122.22%
LifeMD
Nov 18, 2025
Maintains: Buy
Price Target: $14 → $8
Current: $3.00
Upside: +166.67%
Tandem Diabetes Care
Aug 11, 2025
Downgrades: Hold
Price Target: $75 → $12
Current: $21.14
Upside: -43.24%
AVITA Medical
Aug 11, 2025
Maintains: Buy
Price Target: $14 → $8
Current: $4.75
Upside: +68.42%
P3 Health Partners
Apr 21, 2025
Maintains: Buy
Price Target: $50 → $20
Current: $2.31
Upside: +765.80%
LeMaitre Vascular
Feb 28, 2025
Maintains: Buy
Price Target: $105 → $110
Current: $107.39
Upside: +2.43%
Beta Bionics
Feb 24, 2025
Initiates: Buy
Price Target: $30
Current: $10.61
Upside: +182.75%
LifeVantage
Dec 19, 2024
Initiates: Buy
Price Target: $26
Current: $4.88
Upside: +432.79%
Harrow
Oct 4, 2024
Maintains: Buy
Price Target: $45 → $55
Current: $36.35
Upside: +51.31%
Alphatec Holdings
Sep 3, 2024
Maintains: Buy
Price Target: $32 → $18
Current: $12.23
Upside: +47.18%
Aug 9, 2024
Maintains: Buy
Price Target: $15 → $20
Current: $8.70
Upside: +129.89%
Jun 28, 2024
Initiates: Buy
Price Target: $5
Current: $2.79
Upside: +79.21%
Feb 15, 2023
Maintains: Buy
Price Target: $20 → $26
Current: $23.88
Upside: +8.88%
Apr 8, 2022
Initiates: Buy
Price Target: $11
Current: $0.20
Upside: +5,427.64%
Sep 15, 2020
Initiates: Buy
Price Target: $128
Current: $23.17
Upside: +450.28%